Retinoic acid receptor α (RARα) plays a crucial role in kidney disease. However, the underlying mechanisms in glomerulosclerosis (GS) is still not clear. The roles of RARα in an adriamycin (ADR)-induced GS rat model and in ADR-induced podocyte injury in vitro were investigated. RARα was over-expressed in GS rats, and serum, urine and kidney samples were collected to detect the induction of the expression of the receptor. RARα expression was inhibited and/or over-expressed in cultured podocytes following injury, as demonstrated by morphometric assays, cell toxicity, and matrix metalloproteinase (MMP) enzymatic activity. RARα displayed a renoprotective role in GS rats, resulting in a lower GS index, podocyte foot process fusion, and proteinuria, reduced serum creatinine and blood urea nitrogen. Further experiments indicated that RARα inhibited the accumulation of TGF-β1, α-smooth muscle actin, collagen IV, and fibronectin, while it induced MMP2 and MMP9 excessive expression in podocytes in vitro. RARα improved the renal function and attenuated the progression of GS that was associated with the over-expression of MMP2 and MMP9.
Introduction
Glomerulosclerosis (GS) is a disease that is characterized by excessive extracellular matrix (ECM) deposition in the glomerulus and is accompanied with increased transforming growth factor-β1 (TGF-β1) expression. Nephrotic-range proteinuria is a common pathological feature of chronic kidney diseases (CKD) that leads to the development of end-stage renal disease (ESRD) and ultimately to a progression of renal malfunctions [1] [2] [3] . Podocytes are extremely ramified cells that are localized in glomerulus of the kidney.
Podocytes play crucial role in the maintenance of the glomerular filtration barrier. Podocyte injury mainly contributes to the development of GS [4, 5] . To date, no effective curative strategy for GS has been developed. Therefore, the investigation of the underlying mechanism and the factors that contribute to disease progression is of particular interest.
Matrix metalloproteinases (MMPs) are a family of zincdependent and calcium-dependent endopeptidases that play a key role in maintaining the balance between the matrix degradation and the reconstruction of tissue homeostasis [6] . Gelatinases comprise a key subgroup of MMPs, including MMP2 and MMP9 [7] [8] [9] . In kidney, MMP2 and MMP9 are mainly detected at the glomerular basement membrane (GBM) and the mesangial area, exerting critical roles in the glomerular function and the decomposition of the ECM [10] . MMP2 and MMP9 notably degrade the majority of the proteins of the GBM, including collagen IV (Col-IV) and fibronectin (FN) [11] [12] [13] . Therefore, abnormal expression levels of gelatinases could play a prominent role in the pathogenesis of GS.
Nuclear receptors, namely retinoic acid receptor (RAR) and peroxisome proliferator-activated receptor (PPAR), act as an integrated conduit for environmental and hormonal signals that aim to govern genomic responses and to exert specific biological effects (i.e. cell growth and development, differentiation, and gene transcription) [14, 15] . Previous studies have shown that all-trans retinoic acid (ATRA), a ligand of RARs, could regulate gelatinases in GS rats [13, 16] . RARα is one of the three different subtypes of RARs, namely RARα, RARβ, and RARγ [17] . Several recent investigations have suggested that RARα plays a significant role in kidney disease, although the underlying mechanism of RARα in kidney disease remains unclear [18] [19] [20] . For example, RARα is implicated in human immunodeficiency virus (HIV)-associated nephropathy [18] [19] [20] . Previous studies conducted by our group demonstrated that RARα was associated with the accumulation of the ECM in the progression of renal interstitial fibrosis (RIF) in rats [21] . In addition, the study also reported that RARα expression was suppressed in adriamycin (ADR)-induced podocyte injury and was accompanied with a down-regulation of MMP2 and MMP9 mRNA/protein expression. However, ATRA treatment has been shown to upregulate the expression of RARα, RARγ, MMP2, and MMP9 proteins [22, 23] . Currently it is not well known whether RARα is involved in the metabolism of the ECM. In addition, the contribution of RARα and gelatinases in the induction of podocyte injury in GS remains elusive. Therefore, in the present study we examined the induction of GS in rats and in vitro cultured podocytes in association with the expression and biological effects of RARα on MMP2, MMP9 enzymes and on ECM deposition.
Materials and Methods

Animal treatment
Healthy male Wistar rats (n = 40, 180~200 g) were provided by the Experimental Animal Center of the Guangxi Medical University (Nanning, China). All rats were maintained in a temperature-and humidity-controlled room with alternating 12-h light/dark cycles. The animals were acclimatized for a week. The rats were randomly divided into four groups as follows: (i) sham operation group (SHO), that was a control group subject to a sham operation and tail vein injection of normal saline solution; (ii) model group that was subject to uninephrectomy, and after 1 week to a single tail vein injection of ADR (Wanle Pharmaceutical, Shenzhen, China) at a dose of 5 mg/kg body weight (GS); (iii) GS rats treated with lentivirus carrying RARα injection (GS + RARα transfected); and (iv) GS rats treated with control lentiviral injection (GS + blank virus). Each group comprised 10 animals (n = 10). The lentiviral vectors carrying the RARα gene and the control viruses were purchased from GeneChem (Shanghai, China). Rats in the GS + RARα transfected group and the GS + blank virus group were injected via a subcapsular route into the rat kidney at the 11th week following surgery. Briefly, lentivirus was injected in a renal sub capsule with a 50-μl syringe (Gaoge, Shanghai, China). The needle was injected slowly and held in place for 5 min, and each kidney was injected twice on different sites with 25 μl each time. In total, each rat was injected with 50 μl of lentivirus (5 × 10 8 transducing units/ml).
All rats from the aforementioned four groups were sacrificed at the end of the 12th week post-operative period and the kidneys were removed. Each kidney was divided into four parts. The first part was fixed with 2.5% glutaraldehyde (Sangon Biotech, Shanghai, China) for transmission electron microscopy (TEM) in order to observe the podocyte foot process in the glomeruli. The second part was fixed with 10% neutral formaldehyde (Sangon Biotech) for histological assessment, whereas the third part was frozen in liquid nitrogen for RNA extraction. The final part was used to isolate intact glomeruli using the differential sieving method. The tissues were stored at −80°C for western blot analysis.
Laboratory analysis
Urine that was collected at the 24 h interval was used for analysis at the 12th week following surgery, whereas the 24 h urinary protein excretion was determined by the sulfosalicylic acid method. Blood specimens were collected at the end of each experiment prior to the animal sacrifice. Serum creatinine (Scr) and blood urea nitrogen (BUN) levels were measured by standard enzymatic methods using a biochemical test kit (Hitachi, Tokyo, Japan).
Renal morphology
The renal tissues fixed in 10% neutral formaldehyde were dehydrated via a graded ethanol (Amresco, Solon, USA) series and embedded in paraffin (Sigma-Aldrich, St Louis, USA). Then, 4-μm sections were prepared on a microtome and stained with hematoxylin and eosin (H&E; eBioscience, San Diego, USA). Renal damage was observed by light microscopy, and the severity of the renal lesion was defined by the glomerulosclerosis index (GSI). The GSI was calculated according to the method of Raij et al. [24] . A minimum of 30 glomeruli (range: 30-60) in each specimen were examined, and the severity of the lesion was graded from 0 to 4 points in accordance with the percentage of morphological changes on each glomerulus (0 = 0%, 1+ = 1%-25%, 2+ = 26%-50%, 3+ = 51%-75%, 4+ = 76%-100%). The number of glomeruli showing a lesion of 0 was n 0 , of 1 + n 1 , of 2 + n 2 , of 3 + n 3 and of 4 + n 4 , respectively. The GSI was calculated using the following formula:
The scores obtained by two investigators were averaged.
To evaluate the mesangial matrix area of GS (%), the histological sections were further stained with the Periodic Acid-Schiff (PAS; eBioscince). The PAS-positive area of the glomerular tissues was measured using an image analysis software (Image Pro-Plus Version 6.0, Media Cybernetics, USA). For a single glomerulus, more than 30 glomeruli in each specimen were examined. Glomerular sclerosis was expressed as the mean glomerular sclerosis index: sclerotic index = mesangial area/glomerular area × 100%.
Podocytes foot processes (FPs) were observed by TEM. Briefly, a part of renal cortical tissues were fixed with 2.5% glutaraldehyde and 0.2% tannic acid/osmium tetroxide, washed with acetone, and then incubated with 2% osmium tetroxide and a series of increasing concentrations of Epon in acetone. The sample sections were stained with uranyl acetate and lead citrate, and then examined with an H-7650 TEM (Hitachi, Tokyo, Japan) operating at an accelerating voltage of 80 kV.
Immunohistochemical analysis
Renal tissue samples were dehydrated with ethanol, and embedded in paraffin following fixation in 10% neutral formaldehyde. Serial 4-μm sections were collected sequentially on glass slides. The paraffin was removed from the sections with xylene and rehydrated in graded ethanol. In order to retrieve the antigenicity from formalin fixation, the sections were incubated for 10 min in 10 mM sodium citrate buffer using a microwave oven. Endogenous peroxidase activity was blocked by further pretreatment with 3% hydrogen peroxide and methanol. Finally, the sections were incubated with antibodies against TGF-β1 (1:100; Boshide, Wuhan, China), Col-IV (1:100, Novus, Colorado, USA), and FN (1:100; Abbiotec, San Diego, USA) overnight at 4°C. The sections were thoroughly washed with phosphate-buffered saline (PBS) solution and incubated with biotinylated rabbit anti-mouse IgG secondary antibody (Changdao, Shanghai, China) for 30 min. Finally, the sections were stained with diaminobenzidine. PBS solution was used to replace the specific antisera as the negative control. Brownish yellow granular and/or linear deposits in the cells or matrix were interpreted as positive areas. Semi-quantitative evaluation was performed by Image Pro-PluS Version 6.0 Imaging System (Media Cybernetics, Bethesda, USA) at a ×200 original magnification in 30 glomeruli of coded sections for each rat in order to determine the expression of TGF-β1, Col-IV and/or FN. Positive areas for TGF-β1, Col-IV, and FN were extracted by the 'hue saturation method' and expressed as the percentage of discriminated regions (integral optical density/area).
Cell culture, transfection, and injury model
The conditionally immortalized Murine podocytes (MPC5) that were used in the present study were obtained from Prof. Peter Mundel (Massachusetts General Hospital, Boston, USA). Podocytes were cultured in RPMI-1640 (Gibco, New York, USA) containing 10% fetal bovine serum (FBS; Gibco), 100 U/ml penicillin/streptomycin (Solarbio, Beijing, China) at 33°C in a 5% CO 2 incubator. The temperature was then shifted to 37°C for podocyte differentiation. The resulting podocytes exhibited the typical character of mature podocytes which were used in the subsequent experiments.
Lentiviral vectors of RARα-small interfering RNA (siRNA) (RARα − ), negative control siRNA (negative control; based on a scrambled sequence) and lentiviral vectors over-expressing RARα (RARα + ) were all purchased from GeneChem (Shanghai, China).
Podocytes were transfected with lentiviral vectors according to the protocol provided by the manufacturer. The concentration of the lentiviral vector was 1 × 10 8 transducing units/ml, and polybrene (final concentration 50 μg/ml) was added to enhance the lentiviral infection ratio. The podocytes were incubated for 96 h following transfection and then harvested using the Puromycin (0.6 μg/ml; Sigma-Aldrich) test. The population harvested corresponded to podocytes with stable expression of the transduced gene. The cell injury model was induced by ADR as described by Papeta et al. [25] . Briefly, podocytes were incubated for 24 h with complete medium which contained 0.15 μg/ml ADR in order to construct the podocyte injury model. The cells were divided into five groups: (i) normal podocytes (control), (ii) untransduced cells subject to ADR (ADR), (iii) cells transduced with lentivirus carrying RARα-siRNA subject to ADR (ADR-RARα , and ADR-negative control, were incubated with medium that contained ADR for 24 h in order to induce the podocyte injury. The cells were subsequently harvested for morphological evaluation and the detection of the expression of the related biological markers.
Scanning electron microscopy
Sterile coverslips were inserted into 6-well plates and the podocytes were allowed to adhere overnight prior to the ADR treatment that was used to induce injury. Following ADR treatment for 24 h, the coverslips were collected and carefully examined by optical microscopy on an inverted phase-contrast microscope (Olympus, Tokyo, Japan). The ultra-structure of the podocytes was further examined by scanning electron microscopy (SEM). Coverslips in each group were prefixed by immersion in 2% glutaraldehyde in 0.1 M phosphate buffer, and then fixed for 2 h in 1% osmic acid dissolved in PBS. The samples were treated in a graded series of ethanol and tbutyl alcohol solutions, dried in a model ES-2030 freeze dryer (Hitachi), platinum-coated using an IB-5ion coater (Eiko, Kanagawa, Japan), and observed using a VEGA3 SEM system (Tescan, a.s., Brno, Czech Republic).
Cell toxicity assay
The cytotoxicity of podocytes cultured in vitro was quantified by the trypan blue staining. The sample in each group was centrifuged at 500 g and the supernatant was removed. The podocytes in each group was resuspened, and an equal volume of Trypan blue (0.4% solution; Sigma-Aldrich) was added. The solution was incubated at room temperature for approximately 3 min. The sample was placed on a hemocytometer and observed under a bright-field microscope (×400). A total of 200 cells were counted in each group and the experiments were repeated three times. Clear cells were considered to be viable and blue cells were considered non-viable. In addition, the cell death was quantified and calculated as follows: % of trypan blue positive cells = (non-viable cells/number total cells) × 100%.
The methylthiazolyl-tetrazolium bromide (MTT) assay was further used to determinate cell viability. Briefly, podocytes of each group were plated in 96-well culture plates and stimulated as described above. MTT solution (0.5 mg/ml; Sigma-Aldrich) was added to each well and incubated for 4 h. The medium containing the MTT was removed and 200 μl of dimethyl sulfoxide was added to each well for the solubilization of the crystals. The absorbance was monitored at 560 nm using a microplate reader (TECAN, Seestrasse, USA). The absorbance values were used to calculate the cell viability.
Quantitative real-time fluorescent PCR Total RNA was isolated from kidney and cultured podocytes using TRIzol reagent (Invitrogen, Carlsbad, USA). A total of 2 μg of RNA was reverse transcribed using a High Capacity cDNA Reverse Transcriptase Kit (Fermentas, Hanover, USA) according to the protocol provided by the manufacturer. The primers used for the detection of the MMP2, MMP9, RARα, TGF-β1, and β-actin genes by quantitative real-time fluorescent PCR (qRT-PCR) are listed in Table 1 . All primers were synthesized by TaKaRa (Dalian, China). qRT-PCR was conducted using a SYBR Green PCR Master Mix Kit (Roche, Indianapolis, USA) in ABI 7500 qRT-PCR system (Applied Biosystems, Foster, USA). The cycling conditions included a denaturation step at 95°C for 10 min, followed by 36 cycles of an annealing step at 95°C for 15 s and an extension step at 64°C for 1 min. The relative mRNA expression was normalized to β-actin and calculated using the 2 −ΔΔCt method [26] .
Western blot analysis
Renal tissue and cultured podocytes were lysed with radioimmunoprecipitation assay (RIPA) lysis buffer containing a protease inhibitor cocktail (Sigma-Aldrich). Equal amounts of total protein (40 μg) was subject to 8%-15% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Boston, USA). After block with PBS containing 5% non-fat dry milk for 1 h at room temperature, the membranes were incubated with the primary antibodies against the following proteins, namely RARα (1:800; Abcam, Cambridge, UK), MMP2 (1:1000; Abcam), MMP9 (1:1000; Abcam), TGF-β1 (1:1000; CST, Danvers, USA), α-SMA (1:1500; Abcam), COL-IV (1:500; Abcam), FN (1:5000; Abcam), and β-actin (1:1000; CST) overnight (14-16 h) at 4°C. After extensive wash with PBS/Tween-20, the membranes were incubated with HRPconjugated goat anti-rabbit IgG secondary antibodies (Abcam) for 1 h at room temperature. Finally, the blots were detected with the Western Bright TM enhanced chemiluminescent (ECL) system (Advansta, Menlo Park, USA) and exposed to X-ray films for visualization of the protein bands. The experiments were repeated 6 times. The semiquantitative evaluation was carried out using the Gel Doc computerized image analysis system (Bio-Rad, Hercules, USA).
Gelatin zymography analysis
Gelatin zymography (Applygen Technologies, Beijing, China) assay was conducted for the detection of MMP2 and MMP9 enzymatic activities and all steps were carried out according to the instructions provided by the manufacturer. The supernatants derived from podocyte cultures were collected and centrifuged at 12,000 g for 5 min. The bicinchoninic acid (BCA; Beyotime, Shanghai, China) method was used to detect the protein content in the supernatant. Equal amount of supernatants (50 μg) were mixed with sample buffer and subject to electrophoresis. The gels were incubated with 1 × buffer A, 1 × buffer B, followed by coomassie blue (Applygen Technologies) staining and destaining. The activities of the gelatin-degrading enzymes in gels were determined by the Gel Doc computerized image analysis system (Bio-Rad).
Statistical analysis
All data are shown as the mean ± SD. One-way analysis of variance (ANOVA) with post-hoc Fisher's LSD (least significant difference) was used to compare the differences in parameters measured among the experimental groups. The data that followed normal distribution were analyzed. The parameters that did not follow a normal distribution were analyzed by the Kruskal-Wallis test with the post-hoc Mann-Whitney test. The statistical analysis was carried out using SPSS 21.0 (SPSS Inc., Chicago, USA). P < 0.05 was considered as statistically significant.
Results
RARα over-expression ameliorated ADR-induced GS in rats
Lentiviral-based vectors were used to deliver the RARα gene into ADR-induced GS rats. H&E staining indicated that the extent of fibrosis observed in the glomeruli of the GS group was higher than that in the SHO control group. This was reflected by the difference in GSI, as shown in Fig. 1A ,D (P < 0.01). The GSI in the GS+RARα transfected group was notably decreased compared with the GS group ( Fig. 1A,D ; P < 0.01). The differences between the negative control viruses group and the GS group were not statistically significant ( Fig. 1A,D ; P > 0.05). Similar results were obtained when PAS staining was used as a marker of sclerotic index (Fig. 1B,E) . TEM indicated that the podocyte FPs of SHO rats was long and thin ( Fig. 1C) , while the podocytes FPs of GS rats showed diffuse effacement and fusion. The FPs structures were partially recovered in the GS + RARα transfected group compared with the GS group (Fig. 1C) , although the GS+blank vector group exhibited diffused effacement of FPs. However, the transfection of lentiviral-based vectors in the rat kidney did not alter the body weight of GS rats compared with the GS group (Fig. 1F , P > 0.05).
Moreover, the proteinuria level was increased sharply in GS rats compared with SHO rats (54.6 ± 7.6 mg/24 h versus 8.6 ± 3.2 mg/ 24 h, P < 0.01), whereas RARα over-expression in GS rats significantly attenuated proteinuria (34.5 ± 5.7 mg/24 h versus 54.6 ± 7.6 mg/24 h, P < 0.01) (Fig. 1G) . The difference between the negative control viruses group and the GS group was not statistically significant ( Fig. 1G, P > 0.05) . Furthermore, the Scr and BUN were elevated in the GS rats compared with the SHO rats, whereas the Scr and BUN were decreased in GS+RARα transfected rats compared with the GS rats ( Fig. 1H,I ; P < 0.05 for Scr, P < 0.01 for BUN).
RARα over-expression prevented ADR-induced TGF-β1 and α-SMA deposition in vivo
Since the results from the renal morphology and laboratory analysis suggested that increased RARα expression caused remission of the severity of GS, we further analyzed the proteins involved in the ECM, namely Col-IV, FN, and profibrotic growth factor TGF-β1. Immunohistochemistry results revealed that the levels of Col-IV, FN, and TGF-β1 were approximately 10-, 6-, and 7-fold higher in the glomeruli of GS rats than those in the corresponding tissues of the SHO rats ( Fig. 2A-C , P < 0.01). The expression levels of Col-IV, FN, and TGF-β1 in rat glomeruli tissues were apparently suppressed in the GS+RARα transfected group compared with the GS model group ( Fig. 2A-C , P < 0.01). The differences in the staining for all 
. RARα expression ameliorated ADR-induced GS in rats (A) H&E staining in rat glomeruli (×200). (B) PAS staining of glomeruli (×200). (C) TEM detected foot processes of podocytes in the glomeruli of each group (×30,000). (D, E) Morphometric analysis of kidney histology: GSI and PAS-positive area. (F-I) Characteristics and kidney function in rats: body weight (F); 24 h urinary protein (G); Serum creatinine (H); blood urea nitrogen (I)
. Data are expressed as the mean ± SD (n = 10 per group). *P < 0.05; **P < 0.01; NS: P > 0.05. H&E, hematoxylin-eosin; PAS, Periodic Acid-Schiff.
proteins between the GS group and the control viruses group were not significant (P > 0.05). Western blot analysis revealed that the protein level of TGF-β1 in GS rats was increased compared with that in the SHO rats (Fig. 2D ,E, P < 0.05), whereas the protein level of TGF-β1 in the GS + RARα transfected group was decreased compared with that in GS rats ( Fig. 2D,E ; P < 0.05). The protein levels of TGF-β1 in the GS and control viruses groups did not differ significantly ( Fig. 2D,E ; P > 0.05). In addition, the protein levels of α-SMA in the myofibroblasts of the GS group were increased, whereas they were suppressed in the GS + RARα transfected group (Fig. 2D,F ; P < 0.05).
Anti-fibrotic effect of RARα and its inhibition of EMT were associated with decreased MMP2 and MMP9 expression in vivo
Since the over-expression of RARα in the kidney tissues of the GS group could suppress ECM accumulation, we detected the expression of RARα, MMP2 and MMP9 in the corresponding tissues. Western blot analysis indicated markedly reduced expression of RARα protein in the GS rats compared with the SHO rats ( Fig. 3A,B ; P < 0.01), which suggested that RARα participated in the development of GS. Consequently, the expression level of RARα protein in the GS+RARα transfected group was increased compared with that in the GS group (Fig. 3A,B ; P < 0.01). The differences in the expression of RARα between the GS and the control viruses groups were not significant ( Fig. 3A,B ; P > 0.05), which excludes any interference and/ or impact caused by the viral vector. In addition, MMP2 and MMP9 protein levels were significantly declined in the GS group compared with the SHO group (Fig. 3A ,C,D; P < 0.05; P < 0.01), whereas they were markedly stimulated in the GS+RARα transfected group compared with the GS group (Fig. 3A ,C,D, P < 0.01). No significant difference was noted in the expression of MMP2 and MMP9 between the GS group and the control viruses groups (Fig. 3A,C,D ; P > 0.05).
The mRNA levels of RARα, MMP2, MMP9, and TGF-β1 were determined in order to further assess the expressions of RARα, MMP2, MMP9, and the potential changes in the profibrotic growth factors in the four experimental groups (Fig. 3E-H) . Renal tissues from the GS group showed consistently lower RARα, MMP2, and MMP9 mRNA expression, and higher TGF-β1 mRNA expression compared with the SHO group (Fig. 3E-H , P < 0.05; P < 0.01). However, in the GS + RARα transfected group, the expression levels of RARα, MMP2, and MMP9 mRNA were increased, although the expression of TGF-β1 was reduced significantly, compared with those in the GS group (Fig. 3E-H , P < 0.05; P < 0.01).
Effects of RARα on cell morphology and cell viability in ADR-induced podocyte injury in vitro
The investigation of the effects of RARα on podocyte injury was conducted using podocytes cultured in vitro and subsequent transduction of lentiviral plasmids to construct the silenced (RARα − ) or over-expressed RARα gene (RARα + ) and the corresponding control scrambled gene (negative control) in podocytes. The morphological evaluation was conducted in order to observe the effects of RARα in podocyte-induced injury. A shuttle cell body and ordered arrangement were observed in normal podocytes by inverted optical microscopy. In contrast to normal podocytes, the ADR group showed structural deviation from normal podocyte cellular morphology that resulted in shedding from the cytoplasm, and apparent atrophy. However, partially attached cells were observed (Fig. 4A) . Furthermore, these phenomena were significantly aggravated in the ADR-RARα − group, which showed globular morphology, shrinkage and increased cytoplasm atrophy. However, the ADR-RARα + group exhibited no significant deviation from podocytes compared with the normal group. Similarly, no significant differences in the morphology between the control viruses and the ADR groups were found (data not shown).
The detailed and high-resolution imaging of podocyte FPs was conducted with SEM. In the normal group, the structural integrity of the podocytes and a clear foot process were observed. In the ADR group, the podocyte structure was reduced, and FPs were merged and/or retracted. In the ADR-RARα − group, FPs were merged and completely disappeared, whereas in the ADR-RARα + group, the extension of the cell body and FPs was observed (Fig. 4A) . No significant difference in the podocyte FPs was noted between the control viruses and the ADR groups (data not shown).
Trypan blue staining and MTT assay were used to determine cytotoxicity of podocytes in addition to the morphological changes that were observed previously. Non-viable cells in the ADR group were significantly increased compared with the normal group. Nonviable cells were markedly increased in the ADR-RARα − group but markedly reduced in the ADR-RARα + group, when compared with those in the ADR group (Fig. 4B , P < 0.05). Furthermore, the cell viability (optical density value) in the ADR group was significantly decreased compared with the normal group. The cell viability was markedly reduced in the ADR-RARα − group but markedly increased in the ADR-RARα + group, when compared with that in the ADR group (Fig. 4C , P < 0.05).
Effects of RARα on EMT and ECM in ADR-induced podocyte injury in vitro
To evaluate the effects of RARα on EMT and ECM in podocytes, the protein levels of α-SMA, TGF-β1, Col-IV, and FN were detected. Western blot analysis indicated that the expression levels of α-SMA, TGF-β1, Col-IV, and FN were significantly induced in the ADR group compared with the normal group (Fig. 4D-H , P < 0.01). It is interesting to note that the expression levels of α-SMA, TGF-β1, Col-IV, and FN were significantly increased in the ADR-RARα − group but significantly reduced in the ADR-RARα + group, when compared with the those in the ADR group (Fig. 4D-H , P < 0.01).
The differences noted in all the protein markers investigated between the ADR and control viruses groups were not significant ( Fig. 4D-H , P > 0.05).
Anti-fibrotic effect of RARα and its inhibition of EMT were associated with increased MMP2 and MMP9 expression in ADR-induced podocyte injury in vitro
The protein expression levels of RARα, MMP2 and MMP9 were significantly decreased in podocytes in the ADR group (Fig. 5A-D P < 0.05; P < 0.01) compared with the normal group. Furthermore, the expression levels of RARα, MMP2 and MMP9 proteins were significantly reduced in the ADR-RARα − group but increased in the ADR-RARα + group (Fig. 5A-D , P < 0.01, except for MMP9 P < 0.05) compared with those in the ADR group. However, the expression levels of the RARα, MMP2 and MMP9 proteins in the control viruses group were similar to those found in the ADR group (Fig. 5A -D, all P > 0.05).
qRT-PCR results revealed that the mRNA expression levels of RARα, MMP2, and MMP9 were in agreement with their corresponding protein levels (Fig. 5E -G, P < 0.01). It further revealed that the silencing of the RARα in the ADR injury model increased TGF-β1 mRNA expression, while the over-expression of RARα in the same model reduced the expression of TGF-β1 mRNA ( Fig. 5H, P < 0.01) .
To confirm the effect of RARα on MMP2 and MMP9 in injuryinduced podocytes, MMP zymography assay was conducted in order to detect the activities of MMP2 and MMP9. MMP2 and MMP9 activities in the ADR group were notably attenuated compared with those in the normal control group (Fig. 5I, P < 0.01) . However, the activities of MMP2 and MMP9 were significantly enhanced in the ADR-RARα + group but significantly reduced in the ADR-RARα − group, when compared with those in the ADR group (P < 0.01).
Discussion
GS is a common pathological feature of chronic nephrosis that finally leads to ESRD. The etiology of GS remains largely unknown . Densitometric analysis of protein expression relative to β-actin levels (E-H). Data are expressed as the mean ± SD (n = 6 per group). *P < 0.05; **P < 0.01; NS: P > 0.05.
(with 80% of cases being idiopathic), and little consensus as well on key interventional nodes has been reached. This renders the drug development in the field of GS particular difficult [27] . Thus, the inhibition of the process of GS has emerged as a serious issue on the exploration of therapies against kidney disease. Nuclear RARs are transcriptional regulators that control the expression of specific subsets of genes in a ligand-dependent and/or -independent manner. The RARs include three subtypes, namely RARα, RARβ, and RARγ [17] . Previous studies conducted by our group demonstrated that RARα was associated with ECM accumulation in the progression of RIF in rats [21] , although the mechanism of action remained uncertain. In the present study, the effects of RARα on GS rat and podocyte injury were investigated. ADR nephropathy has been used as an experimental model of GS. This is produced by a single dose of ADR injury to glomerular podocytes that produces loss of podocyte foot process architecture and results in persistent proteinuria and the development of GS [28] . In the present animal experiment, we modified this model by combining intravenous ADR injection with unilateral nephrectomy as reported by Ji et al. [29] . The GS rat model exhibited severe fibrosis of the glomerulus, with significantly diffuse mesangial proliferation, collapsed focal glomerular capillary, foot process fusion, ECM excessive accumulation in glomerulus, aggravated proteinuria, and renal function impairment compared with the SHO rats. The data confirmed the progress of fibrotic changes in the kidney of GS rat in the animal experiment.
TGF-β1 is considered as the most important cytokine in the induction of matrix synthesis during the progress of renal fibrosis and glomerular diseases [30, 31] . Down-regulated and overexpressed TGF-β1 expression ameliorates and deteriorates the progression of mesangial expansion and the accumulation of ECM in the glomerulus, respectively. In addition, the podocyte foot process retraction/effacement in diabetes is deteriorated as demonstrated by Hathaway et al. [32] . α-SMA, a hallmark of myofibroblasts, indicated EMT in the progression of renal dysfunction and GS both in vitro and in vivo renal diseases [33, 34] . Moreover, TGF-β1-induced EMT plays an important role in kidney fibrosis [35] . In the present study, we showed significantly increased expression of TGF-β1 and α-SMA Statistical analysis of enzymatic activities of MMP2 and MMP9 in RARα-silenced and/or over-expressing podocytes with ADR-induced injury. Data are expressed as the mean ± SD (n = 6 per group). *P < 0.05; **P < 0.01; NS: P > 0.05.
in GS rats compared with the SHO group rats. Over-expressed RARα in the kidney tissues of GS rats reduced ECM deposits and ameliorated renal function that was accompanied by reduced expressions of TGF-β1 and α-SMA. These findings indicated that the anti-fibrotic effect of RARα in the GS rats may be in part due to the inhibition of TGF-β1 and EMT that in turn limit the progression to the ECM.
MMP2 and MMP9, also named as gelatinase A and gelatinase B, are members of the MMP family of enzymes which are zincdependent and calcium-dependent endopeptidases. MMP2 and MMP9 are involved in the decomposition of the ECM of the glomerulus during the pathological processes in various glomerular diseases [10, 36] . Hayashi et al. [37] reported that knockout of MMP2 attenuated the protective effects of the angiotensin receptor blocker (ARB) in the resistance towards the progression of ADR-induced GS. Okada et al. [38] examined a large Japanese population and demonstrated that the potentially functional polymorphisms of MMP9 were associated with a risk for the development of CKD. In the present study, MMP2 and MMP9 mRNA/protein expression levels in GS rats were found to be significantly decreased compared with their corresponding levels in SHO rats. These results were similar to the studies by Hayashi et al. [37] and Okada et al. [38] which demonstrated the important roles of MMP2 and MMP9 in kidney disease. Furthermore, RARα over-expression in GS rat kidney markedly induced MMP2 and MMP9 expression compared with GS rats in the absence of treatment. Sekiuchi et al. [10] investigated the renal biopsies of patients with glomerular diseases, and reported that MMP2 was mainly deposited in glomerular capillary loops and the GBM. MMP9 was mainly distributed in the mesangium. Since the important roles played by MMP2 and MMP9 in the degradation of the ECM and glomerulus diseases have been previously documented, the results of the present study implied a signal pathway between RARα and MMP2/9 in the control of GBM synthesis and degradation.
Podocytes play crucial roles in the maintenance of the glomerular filtration barrier [39, 40] and contribute to the GBM turnover by producing matrix components and matrix remodeling enzymes [41] . Podocyte injury mainly contributes to the development of GS [5] . The effects of RARα on podocytes in vitro were further investigated in order to confirm the in vivo results. Silencing of RARα in podocytes and subsequent ADR-induced injury caused atrophy of podocytes, cytoplasm shedding, FPs merging, and disappearance and reduction of cell viability. In contrast to these observations, the overexpression of RARα partly rescued the injury as shown in Fig. 4 . Eisenreich et al. [42] reported that the reduction in the cell viability of injured podocytes was associated with the down-regulation of podoplanin expression that was regulated by microRNA-29b. The data of the present study indicated that over-expression of RARα promoted cell viability of injured podocytes. In addition, the protein levels of α-SMA, TGF-β1, Col-IV, and FN were increased, although the protein/ mRNA levels of MMP2 and MMP9 were decreased in podocytes with ADR-induced injury. The aforementioned results were similar to the study by Yao et al. [43] , in which TGF-β1, Col-IV, and laminin were over-expressed, while MMP2 and MMP9 expression was decreased in Angiotensin II-induced podocyte injury in vitro. Furthermore, the expression levels of α-SMA, TGF-β1, Col-IV, and FN were significantly increased in the ADR-induced podocyte injury model in the presence of RARα silencing, while the over-expression of RARα reduced α-SMA, TGF-β1, Col-IV, and FN levels in injured podocytes. The latter results demonstrated the protective and anti-fibrotic effects of RARα on podocytes, which were similar to the in vivo results. Further assays indicated that RARα silencing in injured podocytes reduced the mRNA/protein expression and enzymatic activities of MMP2 and MMP9, while the over-expression of RARα induced the expression and enzymatic activities of MMP2 and MMP9 in injured podocytes. Thus, RARα exhibited the ability of regulating the derangement of MMP2 and MMP9 levels and activities in injured podocytes that were stimulated by ADR in vitro.
In conclusion, the over-expression of RARα in kidney protects the renal function and attenuates the progression of GS in vivo. In addition, it prevents podocytes from ADR-induced injury in vitro. RARα may inhibit the expression levels of TGF-β1 and α-SMA and consequently inhibit excessive accumulation of Col-IV and FN by regulating MMP2 and MMP9 levels. This study may provide additional insight into the prevention of the progression of GS. However, further in vivo and in vitro studies are required to elucidate its protective mechanism.
